These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2387297)

  • 1. Concentrations of temafloxacin in serum and bronchial mucosa.
    Baldwin DR; Wilkinson L; Andrews JM; Ashby JP; Wise R; Honeybourne D
    Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):432-4. PubMed ID: 2387297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of oral lomefloxacin in serum and bronchial mucosa.
    Baldwin DR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1017-9. PubMed ID: 2393260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
    Wise R
    Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
    Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
    J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
    Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
    Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
    J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
    Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
    J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
    Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
    J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Gubbelmans HL; Cremers HM
    J Antimicrob Chemother; 1990 Aug; 26(2):237-46. PubMed ID: 2120178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of enoxacin into human bronchial mucosa.
    Marlin GE; Braude PD; Whelan AJ; Somogyi AA
    Am Rev Respir Dis; 1986 Dec; 134(6):1209-12. PubMed ID: 3466562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of cefpodoxime in serum and bronchial mucosal biopsies.
    Baldwin DR; Wise R; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1992 Jul; 30(1):67-71. PubMed ID: 1429338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of danofloxacin into the respiratory tract tissues and secretions in calves.
    Friis C
    Am J Vet Res; 1993 Jul; 54(7):1122-7. PubMed ID: 8396371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temafloxacin: in vitro comparison with five other antibacterial agents.
    Digranes A; Hardardottir H; Bottolfsen KL
    Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
    Chodosh S
    Am J Med; 1991 Dec; 91(6A):93S-100S. PubMed ID: 1662900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of interaction between temafloxacin and combined oral contraceptive steroids.
    Back DJ; Tjia J; Martin C; Millar E; Mant T; Morrison P; Orme M
    Contraception; 1991 Apr; 43(4):317-23. PubMed ID: 1906791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.